{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 5815"}, "official-title": {"#tail": "\n\t", "#text": "To amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards\n\t\t\t under the Medicare prescription drug program to further transparency of\n\t\t\t payment methodologies to pharmacies, and for other purposes."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20141209", "#text": "December 9, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committees on ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", ", "@committee-id": "HWM00", "#text": "Ways and Means"}, {"#tail": ", and ", "@committee-id": "HAS00", "#text": "Armed Services"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HGO00", "#text": "Oversight and Government Reform"}], "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Collins of Georgia", "@name-id": "C001093"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Loebsack", "@name-id": "L000565"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H9A7F789CDC4D4C05A6C4E9323F395E41", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Generic Drug Pricing Fairness Act", "@value": "Generic Drug Pricing Fairness Act", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H79CF5C742A0444FFBEF5A5DAB871C949"}, {"#tail": "\n    ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Pharmacy benefits manager standards under the Medicare program"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the\n\t\t\t end the following new paragraph:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u201312(b) of the Social Security Act", "@value": "Social Security Act/s:1860D-12/ss:b"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2013112(b)", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w", "@value": "usc/42/1395w"}, "@entity-type": "uscode", "#text": "\n              "}, "@parsable-cite": "usc/42/1395w-112", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "@id": "HF042DE4711AA430188BF271D04B67DE8", "enum": {"#tail": "\n            ", "#text": "(7)"}, "header": {"#tail": "\n            ", "#text": "Pharmacy benefits manager transparency requirements"}, "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": ") to manage the prescription drug coverage provided under such plan, or to control the costs of the\n\t\t\t prescription drug coverage under such plan, unless the PBM adheres to the\n\t\t\t following criteria when handling personally identifiable utilization and\n\t\t\t claims data or other sensitive patient data:", "#text": "PBM"}, "#text": "Each contract entered into with a PDP sponsor under this part with respect to a prescription drug\n\t\t\t plan offered by such sponsor shall provide that the PDP may not enter into\n\t\t\t a contract with any pharmacy benefits manager (referred to in this\n\t\t\t paragraph as a "}, "#text": "\n            ", "subparagraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The PBM may not transmit any personally identifiable utilization or claims data, with respect to a\n\t\t\t plan enrollee, to a pharmacy owned by a PBM if the plan enrollee has not\n\t\t\t voluntarily elected in writing or via secure electronic means to fill that\n\t\t\t particular prescription at the PBM-owned pharmacy."}, "enum": {"#tail": "\n              ", "#text": "(A)"}, "@id": "HBCA69A128B2C44A6B33B96EC57D74554", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "The PBM may not require that a plan enrollee use a retail pharmacy, mail order pharmacy, specialty\n\t\t\t pharmacy, or other pharmacy entity providing pharmacy services in which\n\t\t\t the PBM has an ownership interest or that has an ownership interest in the\n\t\t\t PBM or provide an incentive to a plan enrollee to encourage the enrollee\n\t\t\t to use a retail pharmacy, mail order pharmacy, specialty pharmacy, or\n\t\t\t other pharmacy entity providing pharmacy services in which the PBM has an\n\t\t\t ownership interest or that has an ownership interest in the PBM, if the\n\t\t\t incentive is applicable only to such pharmacies."}, "enum": {"#tail": "\n              ", "#text": "(B)"}, "@id": "HB178A6761D8248DDBD1CF9EDF7DFC098", "#text": "\n              "}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H93A0628EE023435CB7071A614EB13B2C"}, "#text": "\n        ", "@id": "H29B0D3EA6FAA497AA4508356D4A729FC"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\n\t\t\t to read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Paragraph (6) of section 1860D\u201312(b) of the Social Security Act", "@value": "Social Security Act/s:1860D-12/ss:b/p:6"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2013112(b)", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w", "@value": "usc/42/1395w"}, "@entity-type": "uscode", "#text": "\n              "}, "@parsable-cite": "usc/42/1395w-112", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Regular update of prescription drug pricing standard"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "subparagraph": [{"#tail": "\n            ", "clause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "update such standard not less frequently than once every 7 days, beginning with an initial update\n\t\t\t on January 1 of each year, to accurately reflect the market price of\n\t\t\t acquiring the drug;"}, "enum": {"#tail": "\n                ", "#text": "(i)"}, "@id": "HFACB2A06305245B8AA3F716F23F869DC", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "disclose to applicable pharmacies the sources used for making any such update;"}, "enum": {"#tail": "\n                ", "#text": "(ii)"}, "@id": "HD472BDDB56E74DEAAB119F3D47B6136B", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "if the source for such a standard for reimbursement is not publicly available, disclose to the\n\t\t\t applicable pharmacies all individual drug prices to be so updated in\n\t\t\t advance of the use of such prices for the reimbursement of claims; and", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(iii)"}, "@id": "HD81174171B7241D7BA3BD214825545BF", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "establish a process to appeal, investigate, and resolve disputes regarding individual drug prices\n\t\t\t that are less than the pharmacy acquisition price for such drug.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(iv)"}, "@id": "H19349341C333496B96AA4F42397ABC44", "#text": "\n                "}], "enum": {"#tail": "\n              ", "#text": "(A)"}, "header": {"#tail": "\n              ", "#text": "In general"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "If the PDP sponsor of a prescription drug plan uses a standard for reimbursement (as described in\n\t\t\t subparagraph (B)) of pharmacies based on the cost of a drug, each contract\n\t\t\t entered into with such sponsor under this part with respect to the plan\n\t\t\t shall provide that the sponsor shall\u2014", "@display-inline": "yes-display-inline"}, "#text": "\n              ", "@id": "H56668C60FFFB4580BD0121B7B085CDD0"}, {"#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "For purposes of subparagraph (A), a standard for reimbursement of a pharmacy is any methodology or\n\t\t\t formula for varying the pricing of a drug or drugs during the term of the\n\t\t\t pharmacy reimbursement contract that is based on the cost of the drug\n\t\t\t involved, including drug pricing references and amounts that are based\n\t\t\t upon average wholesale price, wholesale average cost, average manufacturer\n\t\t\t price, average sales price, maximum allowable cost (MAC), or other costs,\n\t\t\t whether publicly available or not.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(B)"}, "header": {"#tail": "\n              ", "#text": "Prescription drug pricing standard defined"}, "#text": "\n              ", "@id": "H9B1E5BAF2E3F412BBC16C59759D29576"}], "enum": {"#tail": "\n            ", "#text": "(6)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Regular update of prescription drug pricing standard"}, "#text": "\n            ", "@id": "H4759A413C0674DB2B7812280AB6F06E5"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H47696EE176D34FF1B71097B74EFF51D2"}, "#text": "\n        ", "@id": "H1171BB34E3654B62AC87D4DEC666F2DD"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The amendments made by this section shall apply to plan years beginning on or after January 1,\n\t\t\t 2015."}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Effective date"}, "#text": "\n        ", "@id": "HE50116336A5840D382CDB616A1B63447"}], "#text": "\n      ", "@id": "HA83762EC648F4FB2B456E3B060FFA921"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is amended by adding at the end the following new\n\t\t\t paragraph:", "@entity-type": "uscode", "#text": "\n          ", "external-xref": {"#tail": " of title 10, United States Code", "@parsable-cite": "usc/10/1074g", "#text": "Section 1074g(d)", "@legal-doc": "usc"}, "@value": "usc/10/1074g/d"}, "#text": "\n        ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": "\n      ", "#text": "Regular update of prescription drug pricing standard under TRICARE retail pharmacy program"}, "quoted-block": {"@style": "USC", "after-quoted-block": {"#tail": "\n      ", "#text": "."}, "#tail": "\n\t\t", "paragraph": {"@indent": "up1", "#tail": "\n        ", "text": {"#tail": "\n        ", "#text": "To the extent practicable, with respect to the TRICARE retail pharmacy program described in\n\t\t\t subsection (a)(2)(E)(ii), the Secretary shall ensure that a contract\n\t\t\t entered into with a TRICARE managed care support contractor includes\n\t\t\t requirements described in ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " to ensure the provision of information\n\t\t\t regarding the pricing standard for prescription drugs.", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 1860D\u201312(b)(6) of the Social Security\n\t\t\t Act", "@value": "Social Security Act/s:1860D\u201312/ss:b/p:6", "@proposed": "true"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n              ", "@entity-type": "uscode", "#text": "42 U.S.C. 1395w\u2013112(b)(6)", "@value": "usc/42/1395w\u2013112/b/6", "@proposed": "true"}, "@parsable-cite": "usc/42/1395w-112", "#text": "\n              \n                ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "#text": "\n          ", "@id": "HB9B33785E8754ED1BBCC1F39FE8388EA"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t", "@id": "HA5AEA8BD77194B5F93EDE4E6CA5FC8A5"}, "#text": "\n      ", "@id": "H66B5C028AE2F4C0B89838E937554B90E"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "4."}, "header": {"#tail": "\n\t\t\t", "#text": "Prescription drug transparency in the Federal Employee Health Benefits program"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", is amended by adding at the end the following new\n\t\t\t subsections:", "@entity-type": "uscode", "#text": "\n            ", "external-xref": {"#tail": " of title 5, United States Code", "@parsable-cite": "usc/5/8902", "#text": "Section 8902", "@legal-doc": "usc"}, "@value": "usc/5/8902"}, "#text": "\n          ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "quoted-block": {"@style": "USC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": ") to manage prescription drug coverage or to control the costs of the prescription drug coverage\n\t\t\t unless the carrier and PBM adhere to the following criteria:", "#text": "PBM"}, "#text": "A contract may not be made or a plan approved under this chapter under which a carrier has an\n\t\t\t agreement with a pharmacy benefits manager (in this subsection referred to\n\t\t\t as a ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n            ", "#text": "(p)"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The PBM may not transmit any personally identifiable utilization or claims data with respect to an\n\t\t\t individual enrolled under such contract or plan to a pharmacy owned by the\n\t\t\t PBM if the individual has not voluntarily elected in writing or via secure\n\t\t\t electronic means to fill that particular prescription at such a pharmacy."}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@id": "HED41315DB83743C6ABC94B96F4BF3FEC", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "The PBM may not require that an individual enrolled under such contract or plan use a retail\n\t\t\t pharmacy, mail order pharmacy, specialty pharmacy, or other pharmacy\n\t\t\t entity providing pharmacy services in which the PBM has an ownership\n\t\t\t interest or that has an ownership interest in the PBM or provide an\n\t\t\t incentive to a plan enrollee to encourage the enrollee to use a retail\n\t\t\t pharmacy, mail order pharmacy, specialty pharmacy, or other pharmacy\n\t\t\t entity providing pharmacy services in which the PBM has an ownership\n\t\t\t interest or that has an ownership interest in the PBM, if the incentive is\n\t\t\t applicable only to such pharmacies."}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "H3EA95B8875FD4FF594B1431C05D26CAE", "#text": "\n              "}], "#text": "\n            ", "@id": "H6780D93564DE4001BA4A2CB43ED7D4B9"}, {"#tail": "\n          ", "#text": "\n            ", "enum": {"#tail": "\n\t\t\t\t\t\t", "#text": "(q)"}, "@id": "HA89248F3B9C24207B424C7FD3FF8551E", "paragraph": [{"@id": "H995BB05E48574A6080E83D6592240070", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "If a contract made or plan approved under this chapter provides for a standard for reimbursement\n\t\t\t (as described in paragraph (2)) with respect to a prescription drug plan,\n\t\t\t such contract or plan shall provide that the applicable carrier\u2014"}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "@display-inline": "yes-display-inline", "#text": "\n              ", "subparagraph": [{"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "update such standard not less frequently than once every 7 days, beginning with an initial update\n\t\t\t on January 1 of each year, to accurately reflect the market price of\n\t\t\t acquiring the drug;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "#text": "\n                ", "@id": "HDE6E2B9DC0A74E6D9B2EFAAEBB714B3D"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "disclose to applicable pharmacies the sources used for making any such update;", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "#text": "\n                ", "@id": "H437CF4AB01864112874E9BC21CA2FC6C"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "if the source for such a standard for reimbursement is not publicly available, disclose to the\n\t\t\t applicable pharmacies all individual drug prices to be so updated in\n\t\t\t advance of the use of such prices for the reimbursement of claims; and"}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "#text": "\n                ", "@id": "H3AD25542FF1341A7A17D2572ABED9533"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "establish a process to appeal, investigate, and resolve disputes regarding individual drug prices\n\t\t\t that are less than the pharmacy acquisition price for such drug."}, "enum": {"#tail": "\n                ", "#text": "(D)"}, "#text": "\n                ", "@id": "H8F2B2FDB8C6B4E939EE026EBA46D0210"}], "@commented": "no"}, {"@indent": "up1", "#tail": "\n          ", "text": {"#tail": "\n            ", "#text": "For purposes of paragraph (1), a standard for reimbursement of a pharmacy is any methodology or\n\t\t\t formula for varying the pricing of a drug or drugs during the term of the\n\t\t\t pharmacy reimbursement contract that is based on the cost of the drug\n\t\t\t involved, including drug pricing references and amounts that are based\n\t\t\t upon average wholesale price, wholesale average cost, average manufacturer\n\t\t\t price, average sales price, maximum allowable cost, or other costs,\n\t\t\t whether publicly available or not."}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H59C765C59834476EB7CC94B7D35A069C"}]}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H21701A0477414A0084832B9EF78BDC7E"}, "#text": "\n        ", "@id": "H3C0DA2A97E5641B1AEEA7F3186C97FB5"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", on or after the date of enactment of this\n\t\t\t section.", "@entity-type": "uscode", "#text": "section 8902 of\n\t\t\t title 5, United States Code", "@value": "usc/5/8902"}, "#text": "The amendment made by subsection (a) shall apply to any contract entered into under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Application"}, "#text": "\n        ", "@id": "H69A3C5D037474EA7B018A21A9F5041D9"}], "#text": "\n      ", "@id": "H301A775B2A9F4471AD17307489442EBD"}], "#text": "\n\t\t", "@id": "H1A735E6D193C4321A81F50026F5BD812"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-12-09"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 5815 IH: Generic Drug Pricing Fairness Act"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}